Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Cann Group ( (AU:CAN) ) has shared an announcement.
Cann Group Limited has announced the quotation of 120,395,238 ordinary fully paid securities on the Australian Securities Exchange (ASX) as of October 31, 2025. This move is part of previously announced transactions and is expected to enhance the company’s financial flexibility and market presence, potentially impacting its operational capabilities and stakeholder interests positively.
More about Cann Group
Cann Group Limited operates in the pharmaceutical industry, focusing on the cultivation and production of medicinal cannabis products. The company is positioned to cater to the growing demand for cannabis-based therapies, leveraging its expertise in plant genetics and cultivation technologies.
YTD Price Performance: -66.67%
Average Trading Volume: 2,682,654
Technical Sentiment Signal: Sell
Current Market Cap: A$9.15M
For an in-depth examination of CAN stock, go to TipRanks’ Overview page.

